As of 2025-05-06, the Intrinsic Value of Lexington Biosciences Holdings Corp (LXGTF) is -0.82 USD. This LXGTF valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.00 USD, the upside of Lexington Biosciences Holdings Corp is -816,548.40%.
Based on its market price of 0.00 USD and our intrinsic valuation, Lexington Biosciences Holdings Corp (LXGTF) is overvalued by 816,548.40%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -0.82 - -0.82 | -0.82 | -816,548.40% |
| P/E | (0.00) - (0.00) | (0.00) | -1732.9% |
| DDM - Stable | (0.62) - (7.67) | (4.14) | -4145033.5% |
| DDM - Multi | (0.63) - (6.01) | (1.13) | -1131278.0% |
| Market Cap (mil) | 0.00 |
| Beta | 1.00 |
| Outstanding shares (mil) | 3.79 |
| Enterprise Value (mil) | 0.00 |
| Market risk premium | 4.60% |
| Cost of Equity | 6.05% |
| Cost of Debt | 5.00% |
| WACC | 4.86% |